Galapagos and Gilead Discontinue Phase 3 ISABELA Program of Ziritaxestat in IPF
Galapagos and Gilead have halted the phase 3 ISABELA program, consisting of two studies evaluating ziritaxestat in patients with idiopathic […]
Galapagos and Gilead have halted the phase 3 ISABELA program, consisting of two studies evaluating ziritaxestat in patients with idiopathic […]
A group of Finish and American research study results show that COVID-19 outcome is mediated primarily through respiratory distress. Risk […]
Amgen and AstraZeneca announced positive results from NAVIGATOR, a phase 3 trial evaluating tezepelumab versus placebo, both added to standard […]
Pfizer presented data from a phase 3 trial of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate in adults 18 years […]
Regeneron and Sanofi announced positive results from the phase 3 LIBERTY ASTHMA VOYAGE trial which evaluated Dupixent (dupilumab) in children aged […]
Corbus Pharmaceuticals announced topline results from its 28-week Phase 2b study (CF-002) of lenabasum in patients with cystic fibrosis (CF). […]
AstraZeneca presented data from its ADAURA Phase III trial showing that Tagrisso (osimertinib) demonstrated clinically meaningful improvement in central nervous […]
UK-based, publicly traded Synairgen’s stock (LSE:SNG) price exploded recently after positive clinical trial results, while the company has to issue […]
The government of the United Kingdom (UK) approved dexamethasone, a commonly prescribed steroid treatment, as a COVID-19 therapy thanks to […]
Acceleron Pharma presented positive topline results from the phase 2 PULSAR trial evaluating sotatercept versus placebo for the treatment of […]